Our earlier report described that EVI1 binds to the potential binding site around miR-96 in pancreatic cancer cells and that miR-96 has a potential binding site at 3′-UTR of KRAS in pancreatic cancer cells [21]. This evidence concerns the gene KRAS and pancreatic neoplasm.